Tarsus Pharmaceuticals, Inc. (TARS) Form 10-K Annual Reports
Tarsus Pharmaceuticals, Inc. (TARS) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: TARS
CIK: 1819790
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerCheryl Moreno
Audit LocationIrvine, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| S-3ASR | 2026-10-13 | — | S-3ASR | 0001193125-26-420618 | View SEC Doc Filr Page |
| S-3ASR | 2026-10-13 | — | S-3ASR | 0001193125-26-420490 | View SEC Doc Filr Page |
| 8-K/A | 2026-10-13 | 2026-09-04 | 8-K/A | 0001819790-26-000069 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-15 | FORM 4 | 0001051578-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-15 | FORM 4 | 0001181186-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-15 | FORM 4 | 0001228684-26-000010 | View SEC Doc Filr Page |
| 144 | 2026-09-15 | — | 144 Filing | 0001628280-26-062078 | View SEC Doc Filr Page |
| 8-K | 2026-09-10 | 2026-09-04 | 8-K | 0001819790-26-000066 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-04 | FORM 4 | 0001827672-26-000013 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-04 | FORM 4 | 0001842190-26-000011 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-04 | FORM 4 | 0001827584-26-000013 | View SEC Doc Filr Page |
| 144 | 2026-09-04 | — | 144 Filing | 0001628280-26-060766 | View SEC Doc Filr Page |
| 144 | 2026-09-04 | — | 144 Filing | 0001959173-26-006760 | View SEC Doc Filr Page |
| 144 | 2026-09-04 | — | 144 Filing | 0001959173-26-006758 | View SEC Doc Filr Page |
| 144 | 2026-09-04 | — | 144 Filing | 0001959173-26-006753 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-02 | FORM 4 | 0001827672-26-000011 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | FORM 4 | 0001842190-26-000009 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0001959173-26-006670 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0001959173-26-006653 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0001959173-26-006652 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0001628280-26-060042 | View SEC Doc Filr Page |
| 144 | 2026-09-01 | — | 144 Filing | 0001959173-26-006607 | View SEC Doc Filr Page |
| 144 | 2026-09-01 | — | 144 Filing | 0001959173-26-006596 | View SEC Doc Filr Page |
| 144 | 2026-08-25 | — | 144 Filing | 0001959173-26-006443 | View SEC Doc Filr Page |
| 144 | 2026-08-19 | — | 144 Filing | 0001959173-26-006221 | View SEC Doc Filr Page |